Table 3 Genotypic drug resistance test results of 39 study participants on ART with viral load >1000 copies/mL

33

EFV/3TC/AZT

-

190,343

K103N,M184V

34

NVP/3TC/D4T

-

50,626

G190A,M184V,D67N,K219Q

65

NVP/3TC/D4T

-

118,402

V108I,Y181C,M184V,T210W

71

NVP/3TC/D4T

-

141,470

Y181C,M184V

87

EFV/3TC/D4T

30,661

K103N,V108I,M184V,T215F

88

EFV/3TC/AZT

42,764

K103N,P225H,M184V

92

NVP/3TC/D4T

34,335

Y181C,M184V

107

NVP/3TC/D4T

-

66,838

Y181C,M184V

150

NVP/3TC/D4T

-

1,309

K103N,V108I,M184V

158

EFV/3TC/AZT

NVP/D4T

220,347

K103N,V108I,P225H,M184V,M41L,D67N,K70R,V75M,T215Y,K219Q

160

NVP/3TC/D4T

EFV

32,840

Y181C,M184V,T69N

212

NVP/3TC/D4T

-

10,627

G190A,M184V

216

EFV/3TC/AZT

-

15,161

M41L

240

NVP/3TC/D4T

-

229,960

K103N,M184V

247

NVP/3TC/D4T

-

2,611

Y181C,G190A,M184V

302

NVP/3TC/D4T

EFV/AZT

3,564

K103N,Y181CM184V

326

EFV/3TC/AZT

NVP/D4T

148,750

K103N,G190A,M184V,D67N,K70R,K219Q

348

NVP/3TC/D4T

-

18,596

Y181C,M184V,K65R*

353

NVP/3TC/D4T

-

1,614

Y181C,M184V

354

NVP/3TC/D4T

4,326

K103N,V108I,M184V,T215F

364

NVP/3TC/D4T

-

17,232

K103N,M184V

377

NVP/3TC/D4T

-

13,088

G190A,M184V

380

EFV/3TC/AZT

-

2,814

K103N,G190A,M184V

407

NVP/3TC/D4T

-

25,634

G190A,M184V

427

NVP/3TC/D4T

-

98,367

K103N,M184V,T215Y

459

NVP/3TC/D4T

-

13,404

G190S,M184V

463

NVP/3TC/D4T

-

54,432

Y181C,G190A,M184V

467

NVP/3TC/D4T

-

30,253

M184V,D67N,K70R,K219E

472

NVP/3TC/D4T

ABV

11,806

G190A,M184V,D67N,K70R,K219Q

477

NVP/3TC/D4T

-

39,783

V108I,Y181C,M184V,D67N,K70R,K219Q

487

NVP/3TC/D4T

EFV/AZT/TDF

17,980

K103N,Y188L,M184V,M41L,L210W,T215Y